{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:06Z","timestamp":1792783626777,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LFB Biomedicaments"},{"name":"Baxter GmbH"},{"name":"CSL Behring GmbH"},{"name":"Mitsubishi Tanabe"},{"name":"TEM International"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bja.2020.12.010","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T18:39:04Z","timestamp":1607539144000},"page":"590-598","source":"Crossref","is-referenced-by-count":111,"title":["Impaired fibrinolysis in critically ill COVID-19 patients"],"prefix":"10.1016","volume":"126","author":[{"given":"Mirjam","family":"Bachler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"B\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"St\u00fcrzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Giebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Str\u00f6hle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F.","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2020.12.010_bib1","series-title":"Epidemiological Update, Coronavirus disease 2019 (COVID-19)","year":"2020"},{"key":"10.1016\/j.bja.2020.12.010_bib2","doi-asserted-by":"crossref","first-page":"e00812","DOI":"10.1128\/mBio.00812-20","article-title":"Pandemic COVID-19 joins history\u2019s pandemic legion","volume":"11","author":"Morens","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.bja.2020.12.010_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1714350","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2020.12.010_bib6","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.bja.2020.12.010_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bja.2020.12.010_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2020.12.010_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-019-0499-6","article-title":"Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study","volume":"9","author":"Schmitt","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.bja.2020.12.010_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136463","article-title":"Assessment of fibrinolysis in sepsis patients with urokinase modified thromboelastography","volume":"10","author":"Panigada","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2020.12.010_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection","volume":"231","author":"Wright","year":"2020","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.bja.2020.12.010_bib13","article-title":"Fibrinolysis shutdown and thrombosis in a COVID-19 ICU","author":"Creel-Bulos","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.bja.2020.12.010_bib14","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","article-title":"SAPS 3\u2014from evaluation of the patient to evaluation of the intensive care unit: Part 2. Development of a prognostic model for hospital mortality at ICU admission","volume":"31","author":"Moreno","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bja.2020.12.010_bib16","article-title":"Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery","author":"Groene","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2020.12.010_bib17","article-title":"A\u00a0prospective observational study of the rapid detection of clinically-relevant plasma direct oral anticoagulant levels following acute traumatic injury","author":"Oberladst\u00e4tter","year":"2020","journal-title":"Anaesth"},{"key":"10.1016\/j.bja.2020.12.010_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bja.2020.12.010_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2020.12.010_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection","volume":"231","author":"Wright","year":"2020","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.bja.2020.12.010_bib21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00414-020-02317-w","article-title":"Dying with SARS-CoV-2 infection\u2014an autopsy study of the first consecutive 80 cases in Hamburg, Germany","volume":"134","author":"Edler","year":"2020","journal-title":"Int J Leg Med"},{"key":"10.1016\/j.bja.2020.12.010_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bja.2020.12.010_bib23","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3324\/haematol.2019.217463","article-title":"Platelet HIF-2\u03b1 promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release","volume":"104","author":"Chaurasia","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bja.2020.12.010_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/SHK.0000000000001089","article-title":"Thrombin provokes degranulation of platelet \u03b1-granules leading to the release of active plasminogen activator inhibitor-1 (PAI-1)","volume":"50","author":"Huebner","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.bja.2020.12.010_bib25","doi-asserted-by":"crossref","first-page":"104950","DOI":"10.1016\/j.phrs.2020.104950","article-title":"Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study","volume":"158","author":"Viecca","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bja.2020.12.010_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148747","article-title":"Variable resistance to plasminogen activator initiated fibrinolysis for intermediate-risk pulmonary embolism","volume":"11","author":"Stubblefield","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2020.12.010_bib27","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: a plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2174\/138945007781662319","article-title":"The plasminogen activation system in lung disease","volume":"8","author":"Sisson","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bja.2020.12.010_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00408-015-9689-7","article-title":"Clinical significance of intra-alveolar fibrin deposition in transbronchial lung biopsy in patients with organizing pneumonia","volume":"193","author":"Nagata","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.bja.2020.12.010_bib30","doi-asserted-by":"crossref","first-page":"L792","DOI":"10.1152\/ajplung.2001.280.4.L792","article-title":"Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation","volume":"280","author":"Schermuly","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bja.2020.12.010_bib31","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","volume":"18","author":"Wang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2020.12.010_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/TA.0000000000002786","article-title":"Rescue therapy for severe COVID-19 associated acute respiratory distress syndrome (ARDS) with tissue plasminogen activator (tPA): a case series","volume":"89","author":"Barrett","year":"2020","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.bja.2020.12.010_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/qjmed\/hcaa121","article-title":"Plasminogen improves lung lesions and hypoxemia in patients with COVID-19","volume":"113","author":"Wu","year":"2020","journal-title":"QJM"},{"key":"10.1016\/j.bja.2020.12.010_bib34","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3109\/1354750X.2011.587893","article-title":"Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?","volume":"16","author":"Paulus","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.bja.2020.12.010_bib35","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.87a.ccc052","article-title":"Evaluation and management of shock in patients with COVID-19","author":"Fox","year":"2020","journal-title":"Clevel Clin J Med"},{"key":"10.1016\/j.bja.2020.12.010_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2020.12.010_bib37","first-page":"963","article-title":"A\u00a0prospective pilot trial to assess the efficacy of argatroban (Argatra(\u00ae)) in critically ill patients with heparin resistance","volume":"9","author":"Bachler","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bja.2020.12.010_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/MBC.0b013e328317f5aa","article-title":"Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII","volume":"19","author":"Nielsen","year":"2008","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122030996X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122030996X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T10:30:22Z","timestamp":1655893822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709122030996X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S000709122030996X"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2020.12.010","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}